Metastatic Colorectal Cancers Withdrawn Phase 2 Trials for Gefitinib (DB00317)

Also known as: Colorectal cancer metastatic / Metastatic Colorectal Cancer

IndicationStatusPhase
DBCOND0063579 (Metastatic Colorectal Cancers)Withdrawn2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00233623Irinotecan, 5-Fluorouracil and Leucovorin With or Without Iressa in the Treatment of Metastatic Colorectal CancerTreatment